Absorption Systems' GLP facility receives full accreditation from AAALAC

Absorption Systems, a leader in testing drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), announced today that its GLP facility in San Diego, Calif., for preclinical testing of drugs, biologics and medical devices received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The company's GLP-compliant facility provides clients with a broad range of services, experimental models and surgical capabilities, offering clients access to specialized technical staff and equipment, rapid turnaround time and competitive pricing.

“AAALAC's renewal of our accreditation demonstrates not only our dedication to responsible animal care and use, but also our pledge to provide our clients with superior resources and services in advancing their drugs, biologics, or medical devices toward IND, NDA, BLA, IDE, 510(k) or PMA regulatory filings.”

AAALAC is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Institutions volunteer to participate in AAALAC's program in addition to complying with local, state and federal laws that regulate animal research. After an institution earns accreditation, it must be re-evaluated every three years in order to maintain its accredited status. Following a meticulous on-site inspection, AAALAC determined that Absorption Systems' San Diego facility is committed to the highest level of animal care and research practices, resulting in the facility's accreditation renewal.

"Absorption Systems is thrilled that AAALAC has commended our commitment to exceed international standards of animal care," commented Patrick M. Dentinger, president and CEO of Absorption Systems. "AAALAC's renewal of our accreditation demonstrates not only our dedication to responsible animal care and use, but also our pledge to provide our clients with superior resources and services in advancing their drugs, biologics, or medical devices toward IND, NDA, BLA, IDE, 510(k) or PMA regulatory filings."

SOURCE Absorption Systems